Tennessee House Bill HB2101

Tennessee 2025-2026 Regular Session

• Introduced: 2/2/26
• Refer: 2/5/26
• Refer: 3/18/26
• Refer: 3/25/26
• Refer: 3/31/26
• Engrossed: 4/6/26
• Enrolled: 4/10/26
• Passed: 4/27/26
• Chaptered: 5/5/26

Caption

AN ACT to amend Tennessee Code Annotated, Title 39, Chapter 17, Part 4, relative to drugs.

Impact

The proposed changes stand to impact the operational protocols of pharmacies across Tennessee. Pharmacies will be required to implement technologies that connect to an electronic tracking system, ensuring that all prescription and over-the-counter products containing pseudoephedrine or ephedrine are accounted for through electronic submissions. This is intended to reduce the incidence of misuse associated with these substances and promote responsible sales practices. Moreover, the bill also addresses liability issues for pharmacies, providing them with immunity from civil liability as long as they follow the regulations stipulated in this act.

Summary

House Bill 2101 seeks to amend Tennessee Code Annotated regarding the control of drugs, specifically focusing on the sale of products containing pseudoephedrine and ephedrine, which are commonly used as precursors in the synthesis of methamphetamine. The bill updates various sections of the code to incorporate an electronic sales tracking system designed to facilitate real-time monitoring of these substances and prevent illegal purchases. The amendments include stipulations for pharmacies to adopt this system without charge, effectively streamlining the process of tracking sales and enhancing regulatory compliance.

Contention

Contentious aspects of HB2101 may arise from the increased regulatory burden it places on pharmacies, particularly small businesses that might struggle to implement the required technological systems. Some stakeholders could argue that these changes may generate unintended consequences such as decreasing access to necessary medications for legitimate consumers while inadvertently complicating the purchasing process. Furthermore, discussions around privacy and data security for the information collected by the electronic tracking system might emerge, as these systems will collect personal information of purchasers to generate stop-sale alerts.

Further_notes

The bill concludes with provisions for regular updates to the system and financial regulation of fees associated with the tracking process to ensure that the costs remain manageable for all pharmacies involved. This legislative move is part of a broader strategy to combat the ongoing issues surrounding methamphetamine production and abuse in the state, although it may face challenges from advocacy groups concerned about its impacts on personal freedoms.